Advertisement Pharmaceutical Business review -
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
September 29, 2020

Pfizer gets FDA nod for Xeljanz to treat juvenile idiopathic arthritis

Pfizer has secured approval from the US Food and Drug Administration (FDA) for its Xeljanz (tofacitinib) to treat children and adolescents two years and older with active polyarticular course juvenile idiopathic arthritis (pcJIA).

Continue
Pfizer world headquarters in Manhattan, New York. (Credit: Coolcaesar)
September 29, 2020

Inovio announces partial hold on Covid-19 vaccine candidate trial over FDA queries

Inovio has announced partial hold on Covid-19 vaccine candidate trial over FDA additional queries. (Credit: PIRO4D from Pixabay)
September 28, 2020

GSK gets FDA approval for Nucala to treat hypereosinophilic syndrome

GSK's corporate headquarters in Brentford, London. (Credit: SmugMug+Flickr / GlaxoSmithKline plc)

Contracts

September 23, 2020

Sanofi, GSK sign agreements with Government of Canada to supply 72 million doses of adjuvanted Covid-19 vaccine

Sanofi and GSK have signed agreements with the Government of Canada to supply 72 million doses of adjuvanted Covid-19 vaccine. (Credit: Pete Linforth from Pixabay)

Sanofi, GSK sign deal to supply 300 million doses of Covid-19 vaccine in EU states

Catalent to expand manufacturing for Covid-19 vaccine candidate AZD1222

Pfizer, BioNTech sign $1.95bn deal with US govt for supply of Covid-19 vaccine candidate

Deals

Deals September 22, 2020

Roche acquires Irish biotechnology company Inflazome for €380m

Pharmaceutical Business Review

Vifor Pharma Group announces successful sale of OM Pharma

Santen and US ophthalmic company Eyevance enter into share purchase agreement

AstraZeneca acquires Dogma’s oral PCSK9 inhibitor programme

Popular

  1. J&J, GRAM collaborate on manufacturing of Covid-19 vaccine candidate
  2. OncoImmune’s SACCOVID demonstrates significant therapeutic efficacy in Covid-19 trial
  3. J&J begins phase 3 trial of Covid-19 vaccine candidate JNJ-78436735
  4. BMS, bluebird get FDA priority review for ide-cel in multiple myeloma
  5. Sinovac begins Covid-19 vaccine candidate trials in Turkey

PRESS RELEASES

A strong partnership with Thermo Fisher Scientific
A strong partnership with Thermo Fisher Scientific
Pharmaceutical Business Review
Development and Production of the Respimat® Reuseable Inhaler Housing Module
Ensuring regulatory compliance with Brenntag Specialities
Ensuring regulatory compliance with Brenntag Specialities
New laboratory and regulatory services for biotech customers
New laboratory and regulatory services for biotech customers
Pharmaceutical Business Review
Upcoming NSF Webinar: Nitrosamine Impurities; What’s the Impact on IMPs

Suppliers

Whitepapers

Self-Assessment on Nitrosamine Risk Exposure
Self-Assessment on Nitrosamine Risk Exposure
gem-Difluorinated Amines for Drug Design
gem-Difluorinated Amines for Drug Design
eSource Arising: Clinical Data Automation Possibilities Beyond Data Capture
eSource Arising: Clinical Data Automation Possibilities Beyond Data Capture